株式会社D&Mカンパニー Logo

株式会社D&Mカンパニー

Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.

189A | T

Overview

Corporate Details

ISIN(s):
JP3548490006
LEI:
Country:
Japan
Address:
大阪市北区梅田二丁目5番25号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D&M COMPANY CO.,LTD is a specialized provider of comprehensive business support services for the medical, nursing care, and welfare industries. The company offers integrated, one-stop solutions structured around three core pillars: Finance & Investment (F&I), Consulting & Business Renovation (C&Br), and Human Resources & Outsourcing (HR&OS). The F&I division provides financial solutions such as medical fee receivables factoring and leasing. The C&Br division offers management consulting, including organizational reform, profit improvement support, and M&A advisory. The HR&OS division delivers staffing services like personnel placement, temporary staffing, and outsourcing. By holistically addressing key client challenges in finance, management, and human resources, D&M aims to achieve overall business optimization for healthcare and welfare service providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 330.4 KB
2025-08-25 06:04
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.3 MB
2025-08-25 06:04
Registration Form
確認書
Japanese 9.2 KB
2025-01-14 05:43
Report Publication Announcement
確認書
Japanese 9.3 KB
2025-01-14 05:41
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 179.0 KB
2024-08-27 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-08-26 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-08-26 08:00
Annual Report
有価証券報告書-第9期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-06-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-24 02:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-08 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all 株式会社D&Mカンパニー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社D&Mカンパニー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社D&Mカンパニー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060

Talk to a Data Expert

Have a question? We'll get back to you promptly.